It's only when there are at least two female directors on the board that the timeliness of severe product recalls increases; when there are three female directors, the recall decision moves along even faster.
Her outreach to GSK's employees and her discussion of the chief executive's ambition to improve diversity and inclusion helped the publication of targets for female and ethnically diverse representation in senior roles.
